Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2871171
Reference Type
Journal Article
Title
Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--A powerful strategy for breast cancer diagnosis
Author(s)
Silva, CL; Passos, M; Câmara, JS
Year
2012
Is Peer Reviewed?
1
Journal
Talanta
ISSN:
0039-9140
EISSN:
1873-3573
Volume
89
Page Numbers
360-368
Language
English
PMID
22284503
DOI
10.1016/j.talanta.2011.12.041
Web of Science Id
WOS:000301278000052
Abstract
A sensitive assay to identify volatile organic metabolites (VOMs) as biomarkers that can accurately diagnose the onset of breast cancer using non-invasively collected clinical specimens is ideal for early detection. Therefore the aim of this study was to establish the urinary metabolomic profile of breast cancer patients and healthy individuals (control group) and to explore the VOMs as potential biomarkers in breast cancer diagnosis at early stage. Solid-phase microextraction (SPME) using CAR/PDMS sorbent combined with gas chromatography-mass spectrometry was applied to obtain metabolomic information patterns of 26 breast cancer patients and 21 healthy individuals (controls). A total of seventy-nine VOMs, belonging to distinct chemical classes, were detected and identified in control and breast cancer groups. Ketones and sulfur compounds were the chemical classes with highest contribution for both groups. Results showed that excretion values of 6 VOMs among the total of 79 detected were found to be statistically different (p<0.05). A significant increase in the peak area of (-)-4-carene, 3-heptanone, 1,2,4-trimethylbenzene, 2-methoxythiophene and phenol, in VOMs of cancer patients relatively to controls was observed. Statistically significant lower abundances of dimethyl disulfide were found in cancer patients. Bioanalytical data were submitted to multivariate statistics [principal component analysis (PCA)], in order to visualize clusters of cases and to detect the VOMs that are able to differentiate cancer patients from healthy individuals. Very good discrimination within breast cancer and control groups was achieved. Nevertheless, a deep study using a larger number of patients must be carried out to confirm the results.
Keywords
Breast cancer; Urine samples; Solid-phase microextraction; Volatile organic metabolites
Tags
•
Trimethylbenzenes (Interagency Science Discussion Draft)
SAB References
Cited
Cited August 2016
Cited Toxicological Review
Cited Supplemental Information
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity